HOME
   Structured Preceptorship
   Medical Update
   Online Clinical Skills
   Targeted Remediation & Trg
   Goals and Objectives
   Prospective Students
   CME
   Contact Info
   Housing Info
   Links
   In the News
   Resources & Opportunities
   Testimonials

   Admin Access
      

 


 

Continuing Medical Education
 

Accreditation Statement

Structured Preceptorship

The Drexel University College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA: The Drexel University College of Medicine designates this live activity for a maximum of 35 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.   

AOA: This program is eligible for a maximum of 35 credits in Category 2A of the American Osteopathic Association.

Medical Update

The Drexel University College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA: The Drexel University College of Medicine designates this enduring material for a maximum of 85.50 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AOA: This program is eligible for a maximum of 85.50 credits in Category 2A of the American Osteopathic Association.

Faculty Disclosure Statement

It is the policy of Drexel University College of Medicine to insure balance, independence, objectivity, and scientific rigor in all its sponsored educational programs. Speakers at continuing medical education activities are required to disclose to the audience their financial relationships with the manufacturer(s) of any commercial products, goods or services related to the subject matter of the program topic. Any conflicts of interest must be resolved prior to the presentation and announced to the audience. The intent of this disclosure is to allow participants to form their own judgments about the educational content of this activity and determine whether the speaker's commercial interests influenced the presentation. In addition, speakers are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in their presentation.

Faculty Disclosures and Resolution Method

The planning committee and faculty have no relationships to disclose.

  • Christof Daetwyler, M.D.

  • Cynthia Johnson

  • Burton J. Landau, Ph.D.

  • Dennis Novack, M.D.

  • Kathleen Ryan, M.D.
  • Barbara A. Schindler, M.D.

  • Allan B. Schwartz, M.D.

  • Arnold Smolen, Ph.D.

  • Nielufar Varjavand, M.D.

  • Mark B. Woodland, M.D.